Benign prostatic hyperplasia
Our researchers are investigating new methods to treat benign prostatic hyperplasia (BPH). These include novel medications, surgical techniques, minimally invasive procedures and other approaches to improve quality of life and outcomes.
Areas of research in benign prostatic hyperplasia include:
- Minimally invasive therapies, such as holmium laser prostate surgery, also called holmium laser enucleation of the prostate (HoLEP), and water-induced thermotherapy (Aquablation).
- Characterizing subjective patient priorities about procedure characteristics and the impact of these on patient clinical decision-making.
- Identifying standardized and validated quality-of-life values among patients undergoing surgical management of BPH.
- Delineating molecular mechanisms related to the pathobiology of benign prostatic hyperplasia.
Related information